NEUROLOGY 1994;44:1915
© 1994 American Academy of Neurology
A rippling muscle disease gene is localized to 1q41
Evidence for multiple genes
D. A. Stephan, BS,
N.R.M. Buist, MB, ChB, DCH,
A. B. Chittenden, MS,
K. Ricker, MD,
J. Zhou, PhD and
E. P. Hoffman, PhD
Departments of Molecular Genetics and Biochemistry, Human Genetics, and Pediatrics (D.A. Stephan and A.B. Chittenden, and Drs. Zhou and Hoffman), University of Pittsburgh School of Medicine, Pittsburgh, PA; the Department of Pediatrics (Dr. Buist), School of Medicine, Oregon Health Sciences University, Portland, OR; and the Department of Neurology (Dr. Ricker), University of Würzburg, Germany.
Rippling muscle disease (RMD) is an inherited disorder of skeletal muscle in which mechanical stimuli provoke electrically silent contractions. Patient symptoms are muscle cramps, pain, and stiffness, particularly during or following exercise. Clinical signs are balling of muscle following percussion and a characteristic lateral rolling movement of muscle occurring after contraction followed by stretching. We report a new 44-member pedigree segregating RMD as an autosomal dominant trait. A genetic linkage study in this family, using a novel approach of testing closely spaced highly polymorphic markers in affected individuals, localized the responsible gene to the distal end of the long arm of chromosome 1 with a maximum multipoint lod score of 3.56 ( = 0). In this family, RMD is localized to a 12-cM region near D1S235. We studied two previously reported German families for linkage to the same locus, and this same area did not cosegregate with the disease, a finding that shows that different genetic defects can cause a similar clinical phenotype (genetic heterogeneity). An understanding of the defect in contraction control within the muscle fibers in this disease may lead to a better understanding of muscle force transduction, intracellular calcium homeostasis, or both.
Address correspondence and reprint requests to Dr. Eric P. Hoffman, Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Biomedical Science Tower W1211, Pittsburgh, PA 15261.
Supported by NIH grant NS28403.
Received February 25, 1994. Accepted in final form April 11, 1994.
This article has been cited by other articles:

|
 |

|
 |
 
S. Ashok Muley and J. W. Day
Autoimmune rippling muscle
Neurology,
September 23, 2003;
61(6):
869 - 870.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Schara, M. Vorgerd, N. Popovic, B. G.H. Schoser, K. Ricker, and W. Mortier
Rippling Muscle Disease in Childhood
J Child Neurol,
July 1, 2002;
17(7):
483 - 490.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Vorgerd, K. Ricker, F. Ziemssen, W. Kress, H. H. Goebel, W. A. Nix, C. Kubisch, B. G.H. Schoser, and W. Mortier
A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation
Neurology,
December 26, 2001;
57(12):
2273 - 2277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. F. Ansevin, M. Vorgerd, J.-P. Malin, W. Mortier, and C. Kubisch
Phenotypic variability in rippling muscle disease
Neurology,
January 11, 2000;
54(1):
273 - 273.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Vernino, R. G. Auger, A. M. Emslie-Smith, C. M. Harper, and V. A. Lennon
Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability
Neurology,
October 1, 1999;
53(6):
1233 - 1233.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Vorgerd, H. Bolz, T. Patzold, C. Kubisch, J.-P. Malin, and W. Mortier
Phenotypic variability in rippling muscle disease
Neurology,
April 1, 1999;
52(7):
1453 - 1453.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Zhao, P. Loyer, H. Li, V. Valentine, V. Kidd, and A. S. Kraft
Cloning and Chromosomal Location of a Novel Member of the Myotonic Dystrophy Family of Protein Kinases
J. Biol. Chem.,
April 11, 1997;
272(15):
10013 - 10020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. F. Ansevin and D. P. Agamanolis
Rippling Muscles and Myasthenia Gravis With Rippling Muscles
Arch Neurol,
February 1, 1996;
53(2):
197 - 199.
[Abstract]
[PDF]
|
 |
|
|